125 related articles for article (PubMed ID: 15006383)
1. Determination of the stable conformation of GABA(A)-benzodiazepine receptor bivalent ligands by low temperature NMR and X-ray analysis.
Han D; Försterling FH; Li X; Deschamps JR; Cao H; Cook JM
Bioorg Med Chem Lett; 2004 Mar; 14(6):1465-9. PubMed ID: 15006383
[TBL] [Abstract][Full Text] [Related]
2. A study of the structure-activity relationship of GABA(A)-benzodiazepine receptor bivalent ligands by conformational analysis with low temperature NMR and X-ray analysis.
Han D; Holger Försterling F; Li X; Deschamps JR; Parrish D; Cao H; Rallapalli S; Clayton T; Teng Y; Majumder S; Sankar S; Roth BL; Sieghart W; Furtmuller R; Rowlett JK; Weed MR; Cook JM
Bioorg Med Chem; 2008 Oct; 16(19):8853-62. PubMed ID: 18790643
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, in vitro affinity, and efficacy of a bis 8-ethynyl-4H-imidazo[1,5a]- [1,4]benzodiazepine analogue, the first bivalent alpha5 subtype selective BzR/GABA(A) antagonist.
Li X; Cao H; Zhang C; Furtmueller R; Fuchs K; Huck S; Sieghart W; Deschamps J; Cook JM
J Med Chem; 2003 Dec; 46(26):5567-70. PubMed ID: 14667209
[TBL] [Abstract][Full Text] [Related]
4. Unprecedented binding cooperativity between Cu(I) and Cu(II) in the copper resistance protein CopK from Cupriavidus metallidurans CH34: implications from structural studies by NMR spectroscopy and X-ray crystallography.
Chong LX; Ash MR; Maher MJ; Hinds MG; Xiao Z; Wedd AG
J Am Chem Soc; 2009 Mar; 131(10):3549-64. PubMed ID: 19236095
[TBL] [Abstract][Full Text] [Related]
5. Studies of molecular pharmacophore/receptor models for GABAA/benzodiazepine receptor subtypes: binding affinities of substituted beta-carbolines at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis.
Huang Q; Cox ED; Gan T; Ma C; Bennett DW; McKernan RM; Cook JM
Drug Des Discov; 1999 Jul; 16(1):55-76. PubMed ID: 10466057
[TBL] [Abstract][Full Text] [Related]
6. In vivo labelling of alpha5 subunit-containing GABA(A) receptors using the selective radioligand [(3)H]L-655,708.
Atack JR; Alder L; Cook SM; Smith AJ; McKernan RM
Neuropharmacology; 2005 Aug; 49(2):220-9. PubMed ID: 15996568
[TBL] [Abstract][Full Text] [Related]
7. Catalytic mechanism of cyclophilin as observed in molecular dynamics simulations: pathway prediction and reconciliation of X-ray crystallographic and NMR solution data.
Trzesniak D; van Gunsteren WF
Protein Sci; 2006 Nov; 15(11):2544-51. PubMed ID: 17075133
[TBL] [Abstract][Full Text] [Related]
8. SOS-NMR: a saturation transfer NMR-based method for determining the structures of protein-ligand complexes.
Hajduk PJ; Mack JC; Olejniczak ET; Park C; Dandliker PJ; Beutel BA
J Am Chem Soc; 2004 Mar; 126(8):2390-8. PubMed ID: 14982445
[TBL] [Abstract][Full Text] [Related]
9. Determination of the conformation of trimethoprim in the binding pocket of bovine dihydrofolate reductase from a STD-NMR intensity-restrained CORCEMA-ST optimization.
Jayalakshmi V; Krishna NR
J Am Chem Soc; 2005 Oct; 127(40):14080-4. PubMed ID: 16201830
[TBL] [Abstract][Full Text] [Related]
10. X-ray crystallography and NMR reveal complementary views of structure and dynamics.
Brünger AT
Nat Struct Biol; 1997 Oct; 4 Suppl():862-5. PubMed ID: 9377160
[TBL] [Abstract][Full Text] [Related]
11. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
Simard JR; Zunszain PA; Hamilton JA; Curry S
J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
[TBL] [Abstract][Full Text] [Related]
12. NMR in natural products: understanding conformation, configuration and receptor interactions.
Carlomagno T
Nat Prod Rep; 2012 May; 29(5):536-54. PubMed ID: 22456471
[TBL] [Abstract][Full Text] [Related]
13. Characterization of protein-ligand interactions by high-resolution solid-state NMR spectroscopy.
Zech SG; Olejniczak E; Hajduk P; Mack J; McDermott AE
J Am Chem Soc; 2004 Nov; 126(43):13948-53. PubMed ID: 15506755
[TBL] [Abstract][Full Text] [Related]
14. The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABAA receptor.
Kahnberg P; Howard MH; Liljefors T; Nielsen M; Nielsen EØ; Sterner O; Pettersson I
J Mol Graph Model; 2004 Dec; 23(3):253-61. PubMed ID: 15530821
[TBL] [Abstract][Full Text] [Related]
15. Solution structure of the two-iron rubredoxin of Pseudomonas oleovorans determined by NMR spectroscopy and solution X-ray scattering and interactions with rubredoxin reductase.
Perry A; Tambyrajah W; Grossmann JG; Lian LY; Scrutton NS
Biochemistry; 2004 Mar; 43(11):3167-82. PubMed ID: 15023067
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of 1L-1,2:4,5-di-O-isopropylidene-allo-inositol: a comparison of its conformation in solid and solution states.
Sureshan KM; Miyasou T; Watanabe Y
Carbohydr Res; 2004 Jun; 339(8):1551-5. PubMed ID: 15178400
[TBL] [Abstract][Full Text] [Related]
17. Effect of crystal freezing and small-molecule binding on internal cavity size in a large protein: X-ray and docking studies of lipoxygenase at ambient and low temperature at 2.0 A resolution.
Skrzypczak-Jankun E; Borbulevych OY; Zavodszky MI; Baranski MR; Padmanabhan K; Petricek V; Jankun J
Acta Crystallogr D Biol Crystallogr; 2006 Jul; 62(Pt 7):766-75. PubMed ID: 16790932
[TBL] [Abstract][Full Text] [Related]
18. Tricyclic heteroaromatic systems. 2-Phenyl-1,2,4-triazolo[1,5-c][1,3]benzoxazin-5-one: a novel benzodiazepine receptor ligand.
Catarzi D; Cecchi L; Colotta V; Filacchioni ; Martini C; Giusti L; Lucacchini A; Valle G
Farmaco; 1994 Feb; 49(2):89-92. PubMed ID: 8003185
[TBL] [Abstract][Full Text] [Related]
19. Investigation of ligand binding and protein dynamics in Bacillus subtilis chorismate mutase by transverse relaxation optimized spectroscopy-nuclear magnetic resonance.
Eletsky A; Kienhöfer A; Hilvert D; Pervushin K
Biochemistry; 2005 May; 44(18):6788-99. PubMed ID: 15865424
[TBL] [Abstract][Full Text] [Related]
20. Covalent modification of GABAA receptor isoforms by a diazepam analogue provides evidence for a novel benzodiazepine binding site that prevents modulation by these drugs.
Baur R; Tan KR; Lüscher BP; Gonthier A; Goeldner M; Sigel E
J Neurochem; 2008 Sep; 106(6):2353-63. PubMed ID: 18643789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
